National

AstraZeneca doses perfectly safe: Trudeau

Darpan News Desk The Canadian Press, 23 Apr, 2021 05:28 PM

Prime Minister Justin Trudeau says Canadians need not worry about doses of the Oxford-AstraZeneca vaccine coming from the United States.

Trudeau says Canada has been assured the doses being "loaned" by the U.S. were not affected by recent production problems at a facility in Baltimore.

The U.S. has about 30 million surplus doses of the AstraZeneca vaccine, which has been approved in Canada but not yet south of the border.

The Baltimore plant, which ruined 15 million doses of Johnson & Johnson vaccine, is no longer producing the AstraZeneca version.

Trudeau says he was not surprised earlier this week to hear President Joe Biden suggest more vaccines could be coming Canada's way.

Biden mentioned on Wednesday that the U.S. has already provided 1.5 million AstraZeneca doses to Canada and hopes to provide more in the future.

Prev Next

MORE National ARTICLES

Wildlife conservation funding for B.C.

The federal government is investing $2 million over four years to support species at risk and habitat protection in southeastern British Columbia.

Wildlife conservation funding for B.C.

Mars once looked like Canada's High Arctic: study

The deep valleys scarred into the surface of Mars under thick sheets of ice show that the planet once mirrored the Canadian High Arctic, says a new study.

Mars once looked like Canada's High Arctic: study

Insured damage costs rise for Fort McMurray flood

An April flood that led to the evacuation of several northern Alberta communities caused more than half a billion dollars in insured damage.

Insured damage costs rise for Fort McMurray flood

TikTok sale puts Canada between U.S., China

The potential sale of social media platform TikTok to Microsoft is leaving Canada with a sense of deja vu.

TikTok sale puts Canada between U.S., China

COVID app a help even in limited use: Tam

Answering criticism that the federal "COVID Alert" app only works on newer smartphones, Dr. Theresa Tam says it's one of many tools in fighting the novel coronavirus.